Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

On January 28, 2025, Evaxion was given until May 12, 2025, to formally evidence compliance with Nasdaq listing rule 5550 (b) (1) requiring stockholders' equity of at least $2.5 million. The company ...

Vertex Pharmaceuticals Incorporated VRTX reported adjusted earnings of $3.98 per share for the fourth quarter of 2024, ...

with the backing of a robust pipeline and expansion of existing drugs, a well-supported 3.3% dividend yield, and potential for reversion to its mean valuation, MRK could reasonably deliver ...

Sales leaders spend a lot of time reviewing forecasts and monitoring the progress of sales opportunities through the pipeline ... The trap that well-meaning sales leaders fall into is that ...

Omega Healthcare Investors(NYSE: OHI) Q4 2024 Earnings Call Feb 06, 2025, 10:00 a.m. ET ...

Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Acadian Asset Management Incorporated Earnings Conference Call and Webcast for the Fourth Quarter 2024.

“Importantly, this agreement eliminates certain near-term milestone payment obligations related to OST-HER2 in osteosarcoma, projected sales milestone ... within the meaning of the federal ...

Of the 118 biologics losing exclusivity over the next decade, only 10% have biosimilars in development, meaning a vast ...